1. Home
  2. MNKD vs ERO Comparison

MNKD vs ERO Comparison

Compare MNKD & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • ERO
  • Stock Information
  • Founded
  • MNKD 1991
  • ERO 2016
  • Country
  • MNKD United States
  • ERO Canada
  • Employees
  • MNKD N/A
  • ERO N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • ERO
  • Sector
  • MNKD Health Care
  • ERO
  • Exchange
  • MNKD Nasdaq
  • ERO Nasdaq
  • Market Cap
  • MNKD 1.4B
  • ERO 1.3B
  • IPO Year
  • MNKD 2004
  • ERO N/A
  • Fundamental
  • Price
  • MNKD $3.77
  • ERO $15.26
  • Analyst Decision
  • MNKD Buy
  • ERO Strong Buy
  • Analyst Count
  • MNKD 4
  • ERO 1
  • Target Price
  • MNKD $9.75
  • ERO $19.00
  • AVG Volume (30 Days)
  • MNKD 2.6M
  • ERO 480.8K
  • Earning Date
  • MNKD 08-06-2025
  • ERO 07-31-2025
  • Dividend Yield
  • MNKD N/A
  • ERO N/A
  • EPS Growth
  • MNKD 228.27
  • ERO N/A
  • EPS
  • MNKD 0.10
  • ERO 0.18
  • Revenue
  • MNKD $297,595,000.00
  • ERO $489,554,000.00
  • Revenue This Year
  • MNKD $13.72
  • ERO $73.94
  • Revenue Next Year
  • MNKD $15.21
  • ERO $20.16
  • P/E Ratio
  • MNKD $36.35
  • ERO $83.70
  • Revenue Growth
  • MNKD 32.50
  • ERO 13.24
  • 52 Week Low
  • MNKD $3.63
  • ERO $9.30
  • 52 Week High
  • MNKD $7.63
  • ERO $23.40
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 34.62
  • ERO 56.19
  • Support Level
  • MNKD $3.63
  • ERO $14.90
  • Resistance Level
  • MNKD $3.85
  • ERO $15.89
  • Average True Range (ATR)
  • MNKD 0.15
  • ERO 0.52
  • MACD
  • MNKD -0.02
  • ERO -0.08
  • Stochastic Oscillator
  • MNKD 16.47
  • ERO 47.39

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: